The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH).
This
initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network.
This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component.
Through this FOA, applications are sought to conduct basic and pre-clinical studies addressing high impact areas in Alcoholic Hepatitis under the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.